National patterns of medication use during pregnancy

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 8, 2006, Pages 537-545

  Lee, Euni ^a,e   Maneno, Mary K ^a   Smith, Leah ^b   Weiss, Sheila R ^c   Zuckerman, Ilene H ^d   Wutoh, Anthony K ^a   Xue, Zhenyi ^a  

^a HOWARD UNIVERSITY   (United States)

^b GRADY HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^e NONE   (United States)

Author keywords

FDA pregnancy risk category; Medication use; National surveys; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ALPRAZOLAM; ANALGESIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ATENOLOL; CORTISONE; DOXYCYCLINE; ENALAPRIL; ESTROGEN DERIVATIVE; HORMONE DERIVATIVE; LITHIUM; LORAZEPAM; MEDROXYPROGESTERONE; MIDAZOLAM; MULTIVITAMIN; ORAL CONTRACEPTIVE AGENT; PENTOBARBITAL; PROGESTERONE; PROPYLTHIOURACIL; RETINOIC ACID; SIMVASTATIN; TETRACYCLINE; THIAMAZOLE; TOBRAMYCIN; TRIAZOLAM; UNINDEXED DRUG; VALPROATE SEMISODIUM; WARFARIN;

ADULT; AGE; AMBULATORY CARE; ARTICLE; CONSULTATION; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG USE; FEMALE; FOOD AND DRUG ADMINISTRATION; GEOGRAPHY; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PREDICTION; PREGNANCY; PREGNANT WOMAN; PRESCRIPTION; PRIORITY JOURNAL; PRIVATE PRACTICE; RISK ASSESSMENT;

ADULT; AMBULATORY CARE; DRUG PRESCRIPTIONS; DRUG THERAPY; DRUG UTILIZATION; FEMALE; HUMANS; NATIONAL CENTER FOR HEALTH STATISTICS (U.S.); OUTPATIENT CLINICS, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PRESCRIPTIONS, DRUG; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33748354649     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1241     Document Type: Article

References (36)

1. Rajkumar SV. Thalidomide: tragic past and promising future. Mayo Clin Proc 2004; 79 (7): 899-903.
2. Lagoy CT, Joshi N, Cragan JD, et al. Medication use during pregnancy and lactation: an urgent call for public health action. J Women's Health 2005; 14: 104-109.
3. Koren G, Pastuszak A, Shinya I. Drug therapy: drugs in pregnancy. N Engl J Med 1998; 338: 1128-1137.
4. Meadows M. Pregnancy and the drug dilemma. Available at: http:// www.fda.gov/fdac/features/2001/301_preg.html [Accessed 27 August 2002].
5. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287(3): 337-344.
6. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004; 191: 398.
7. Tsui B, Dennehy CE, Tsourounis C. A survey of dietary supplement use during pregnancy at an academic medical center. Am J Obstet Gynecol 2001; 185: 433.
8. Bianco A, Stone J, Lynch L, Lapinski R, Berkowitz G, Berkowitz RL. Pregnancy outcome at age 40 and older. Obstet Gynecol 1996; 87: 917-922.
9. National Center for Health Statistics. Health, US, 2002 with chartbook on trends in the health of Americans (Table 4). Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics, 2002.
10. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transplant 2002; 121: 121-130.
11. Food and Drug Administration. Requirements on content and format of labeling for human prescription drug and biological products. Federal Register 2006; 71: 3921-3997.
12. Weiss SR. Prescription medication use in pregnancy. Medscape Pharmacotherpay 2000 Available at http://www.medscape.com/viewarticle/ 408598 [Accessed on 7 September 2005].
13. Doering PL, Boothby LA, Cheok M. Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks? Am J Obstet Gynecol 2002; 187 (2): 333-339.
14. Haramburu F, Miremont-Salame G, Moore N. Good and bad prescription in pregnancy. Lancet 2000; 356: 1704-2003.
15. Sanz E, Gomez-Lopez T, Martinez-Quintas MJ. Perception of teratogenic risk of common medicines. Eur J Obstet Gynecol Reprod Biol 2001; 95: 127.
16. Cooper WO, Hickson GB, Wayne AR. Prescriptions for contra-indicated category X drugs in pregnancy among women enrolled in TennCare. Paediatr Perinat Epidemiol 2004; 18 (2): 106.
17. Rubin JD, Ferencz C, Loffredo C. Use of prescription and non-prescription drugs in pregnancy. The Baltimore-Washington Infant Study Group. J Clin Epidemiol 1993; 46 (6): 581-589.
18. Brocklebank JC, Ray WA, Federspiel DF, Schaffner W. Drug prescribing during pregnancy; a controlled study of Tennessee Medicaid recipients. Am J Obstet Gynecol 1978; 132: 235-244.
19. Piper JM, Baum C, Kennedy DL. Prescription drug use before and during pregnancy in a Medicaid population. Am J Obstet Gynecol 1987; 157: 148-156.
20. Buitendijk S, Bracken MB. Medication in early pregnancy: prevalence of use and relationship to maternal characteristics. Am J Obstet Gynecol 1991; 165 (1): 33-40.
21. Splinter JY, Sagraves R, Nightengale B, Rayburn WF. Prenatal use of medications by women giving birth at a university hospital. South Med J 1997; 90: 498-502.
22. Bonati M, Bortulas R, Marchetti F, et al. Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 1990; 38: 325-328.
23. Collaborative Group on Drug Use in Pregnancy. Medication during pregnancy: an intercontinental cooperative study. Int J Gynecol Obstet 1992; 39: 185-196.
24. Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL. Prescription of drugs during pregnancy in France. Lancet 2000; 356: 1735-1736.
25. Donati S, Baglio G, Spinelli A. Drug use in pregnancy among Italian women. Eur J Clin Pharmacol 2000; 56 (4): 323-328.
26. De Vigan C, De Walle HEK, Cordier S. Therapeutic drug use during pregnancy: a comparison in four European countries. J Ctin Epidemiol 1999; 52 (10): 977-982.
27. Ly N, McCaig L, Burt CW. National Hospital Ambulatory Medical Care Survey: 1999 Outpatient Department Summary. Advance data from vital and health statistics; no. 321. Hyattsville, Maryland: National Center for Health Statistics, 2001.
28. Cherry DK, Burt CW, Woodwell DA. National Ambulatory Medical Care Survey: 1999 Summary. Advance data from vital and health statistics; no. 322. Hyattsville, Maryland: National Center for Health Statistics, 2001.
29. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 Summary. Advance data from vital and health statistics; no. 328. Hyattsville, Maryland: National Center for Health Statistics, 2002.
30. Ly N, McCaig LF. National Hospital Ambulatory Medical Care Survey: 2000 Outpatient Department Summary. Advance data from vital and health statistics; no. 327. Hyattsville, Maryland: National Center for Health Statistics, 2002.
31. Briggs GG, Freeman R, Yaffe SJ. In Drugs in pregnancy and lactation (5th edn). Williams & Wilkins: Baltimore, 1998; xv.
32. Scialli AR. Anticonvulsants in pregnancy. In Niebyl JR (ed.). Drugs use in pregnancy. Philadelphia, PA: Lea & Febiger: 1988; 45-54.
33. Doering PL, Stewart RB. The extent and character of drug consumption during pregnancy. JAMA 1978; 239: 843-846.
34. Forrest CB, Whelan E-M. Primary care safety-net delivery sites in the United States: a comparison of community health centers, hospital outpatient departments, and physicians' offices. JAMA 2000; 284 (16): 2077-2083.
35. Starfield B, Powe NR, Weiner JR, et al. Costs vs. quality in different types of primary care settings. JAMA 1994; 272 (24): 1903-1908.
36. Sannerstedt R, Lundgorg P, Danielsson BR, et al. Drugs during pregnancy: an issue of risk classification and information to prescribers. Drug Safe 1996; 14: 69-77.